Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.

De Bruin ML, Burgers JA, Baas P, van 't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Aleman BM, van Leeuwen FE.

Blood. 2009 Apr 16;113(16):3679-81. doi: 10.1182/blood-2008-10-184705. Epub 2009 Feb 20.

2.

Consistency and synergy.

Teta MJ, Wagner ME.

Blood. 2009 Aug 27;114(9):2000-1; author reply 2001. doi: 10.1182/blood-2009-05-219071. No abstract available.

3.

[Malignant pleural mesothelioma after radiation treatment for Hodgkin lymphoma].

Vandenbos F, Figueredo M, Dumon-Gubeno MC, Nicolle I, Tarhini A, Butori C, Mouroux J.

Rev Pneumol Clin. 2013 Oct;69(5):291-3. doi: 10.1016/j.pneumo.2013.04.004. Epub 2013 Jun 21. French.

PMID:
23796498
4.

Therapeutic radiation for lymphoma: risk of malignant mesothelioma.

Teta MJ, Lau E, Sceurman BK, Wagner ME.

Cancer. 2007 Apr 1;109(7):1432-8.

5.

Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.

Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ.

J Clin Oncol. 2013 Dec 20;31(36):4544-9. doi: 10.1200/JCO.2013.49.9616. Epub 2013 Nov 18.

6.

Malignant mesothelioma following thoracic radiotherapy for lung cancer.

Witherby SM, Butnor KJ, Grunberg SM.

Lung Cancer. 2007 Sep;57(3):410-3. Epub 2007 May 1. Review.

PMID:
17475364
7.

Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.

De Bruin ML, Dorresteijn LD, van't Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE.

J Natl Cancer Inst. 2009 Jul 1;101(13):928-37. doi: 10.1093/jnci/djp147. Epub 2009 Jun 17.

8.

Malignant mesothelioma following treatment for Hodgkin's disease.

Weissmann LB, Corson JM, Neugut AI, Antman KH.

J Clin Oncol. 1996 Jul;14(7):2098-100.

PMID:
8683242
9.

Malignant mesothelioma following radiation therapy.

Hofmann J, Mintzer D, Warhol MJ.

Am J Med. 1994 Oct;97(4):379-82. Review.

PMID:
7942942
10.

Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma.

Metzger ML, Howard SC, Hudson MM, Gow KW, Li CS, Krasin MJ, Merchant T, Kun L, Shelso J, Pui CH, Shochat SJ, McCarville MB.

Pediatr Blood Cancer. 2006 Mar;46(3):314-9.

PMID:
16086425
11.

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2009 Sep 10;27(26):4239-46. doi: 10.1200/JCO.2008.19.9174. Epub 2009 Aug 10.

12.

Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.

Li X, Brownlee NA, Sporn TA, Mahar A, Roggli VL.

Arch Pathol Lab Med. 2015 Sep;139(9):1129-36. doi: 10.5858/arpa.2014-0569-OA. Epub 2015 Apr 6.

PMID:
25844559
13.

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

van den Belt-Dusebout AW, Aleman BM, Besseling G, de Bruin ML, Hauptmann M, van 't Veer MB, de Wit R, Ribot JG, Noordijk EM, Kerst JM, Gietema JA, van Leeuwen FE.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1420-9. doi: 10.1016/j.ijrobp.2009.01.073.

PMID:
19931732
14.

Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.

Hodgson DC, Koh ES, Tran TH, Heydarian M, Tsang R, Pintilie M, Xu T, Huang L, Sachs RK, Brenner DJ.

Cancer. 2007 Dec 1;110(11):2576-86.

15.

Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma.

Wahner-Roedler DL, Petersen IA.

Drugs Today (Barc). 2004 Oct;40(10):865-79. Review.

PMID:
15605120
17.

Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.

Yan TD, Boyer M, Tin MM, Wong D, Kennedy C, McLean J, Bannon PG, McCaughan BC.

J Thorac Cardiovasc Surg. 2009 Sep;138(3):619-24. doi: 10.1016/j.jtcvs.2008.12.045. Epub 2009 Mar 9.

18.

Malignant mesothelioma mortality--United States, 1999-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Apr 24;58(15):393-6.

19.

Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation.

Patel DA, Kochanski J, Suen AW, Fajardo LF, Hancock SL, Knox SJ.

Cancer. 2006 Feb 1;106(3):718-25.

20.

Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials.

Favier O, Heutte N, Stamatoullas-Bastard A, Carde P, Van't Veer MB, Aleman BM, Noordijk EM, Thomas J, Fermé C, Henry-Amar M; European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group and the Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

Cancer. 2009 Apr 15;115(8):1680-91. doi: 10.1002/cncr.24178.

Items per page

Supplemental Content

Write to the Help Desk